Skip to main content
Advertisement

Glendale Healthcare: Blood Thinner Care Plan Failures - CA

Healthcare Facility:

The failure occurred at Glendale Healthcare Center, where federal inspectors found a resident with cognitive impairment was prescribed both apixaban and clopidogrel bisulfate without the facility creating specific monitoring protocols required by their own policies.

Glendale Healthcare Center facility inspection

Licensed vocational nurse 1 told inspectors during a September 16 interview that Resident 1 lacked a care plan for apixaban use. "Without a care plan, there would not be a goal or specific interventions regarding the use of the specific medication, and the facility could not provide specific care required for Resident 1," the nurse stated.

Advertisement

The nurse was direct about the consequences. "Resident 1 could potentially bleed out and die."

Two minutes later, the same nurse described identical failures with the resident's second blood thinner. Resident 1 had no care plan for clopidogrel bisulfate either. Again, the nurse warned that without specific interventions, "the facility would be lacking care since care was not resident specific."

The nurse repeated the same stark warning: "Resident 1 could potentially bleed out and die."

Blood thinners require careful monitoring because they prevent clotting that stops bleeding. Patients can develop dangerous internal bleeding or bleed excessively from minor injuries without proper oversight. The medications are particularly risky for residents with cognitive impairment who may not recognize or report bleeding symptoms.

The facility's Director of Nursing confirmed both failures during separate interviews with inspectors. At 5:14 PM, the director acknowledged Resident 1 should have had an apixaban care plan "because Resident 1 was receiving that medication and the resident was at risk for bruising and discoloration."

Three minutes later, the director made the same admission about clopidogrel bisulfate. The resident should have had a specific care plan because they were taking the medication and faced bleeding risks.

The facility's own policy, dated March 2022, required exactly what was missing. The policy stated that interdisciplinary teams must develop comprehensive, person-centered care plans for each resident that include "measurable objectives and timeframes" and "describe the services that are to be furnished to attain or maintain the resident's highest practicable physical, mental, and psychosocial well-being."

Care plan interventions must be chosen "only after data gathering, proper sequencing of events, careful consideration of the relationship between the resident's problem areas and their causes, and relevant clinical decision making," according to the policy.

The policy emphasized that interventions should address "the underlying source(s) of the problem area(s), not just symptoms or triggers" and that assessments must be ongoing with care plans revised as conditions change.

Medical records showed the resident was documented as taking both anticoagulant and antiplatelet medications on their Minimum Data Set assessment. This federal assessment tool specifically tracks such medications because of their bleeding risks.

Yet despite this documentation and the facility's detailed policies requiring individualized care plans, staff created none for either blood thinner.

The resident had cognitive impairment that affected daily functioning, making proper medication monitoring even more critical. Cognitively impaired residents may not recognize bleeding symptoms, report pain, or understand restrictions on activities that could cause injury.

Licensed vocational nurse 1's repeated warnings about fatal bleeding highlighted the seriousness of the oversight. Blood thinners can cause life-threatening hemorrhages in the brain, stomach, or other organs without warning signs patients or staff might immediately recognize.

The inspection occurred following a complaint and found the facility failed to meet federal requirements for comprehensive care planning. The violation received a "minimal harm or potential for actual harm" rating affecting few residents.

But the staff's own assessment was more alarming. When the facility's licensed nurse stated twice that a resident "could potentially bleed out and die," the consequences of missing care plans became clear.

The resident continued taking both blood thinners without the individualized monitoring protocols that staff acknowledged were necessary to prevent fatal bleeding.

Full Inspection Report

The details above represent a summary of key findings. View the complete inspection report for Glendale Healthcare Center from 2025-09-17 including all violations, facility responses, and corrective action plans.

Additional Resources

🏥 Editorial Standards & Professional Oversight

Data Source: This report is based on official federal inspection data from the Centers for Medicare & Medicaid Services (CMS).

Editorial Process: Content generated using AI (Claude) to synthesize complex regulatory data, then reviewed and verified for accuracy by our editorial team.

Professional Review: All content undergoes standards and compliance oversight by Christopher F. Nesbitt, Sr., NH EMT & BU-trained Paralegal, using professional regulatory data auditing protocols.

Medical Perspective: As emergency medical professionals, we understand how nursing home violations can escalate to health emergencies requiring ambulance transport. This analysis contextualizes regulatory findings within real-world patient safety implications.

Last verified: May 10, 2026 | Learn more about our methodology

📋 Quick Answer

GLENDALE HEALTHCARE CENTER in GLENDALE, CA was cited for violations during a health inspection on September 17, 2025.

Licensed vocational nurse 1 told inspectors during a September 16 interview that Resident 1 lacked a care plan for apixaban use.

What this means: Health inspections identify deficiencies that facilities must correct. Violations range from minor documentation issues to serious safety concerns. Review the full report below for specific details and facility response.

Frequently Asked Questions

What happened at GLENDALE HEALTHCARE CENTER?
Licensed vocational nurse 1 told inspectors during a September 16 interview that Resident 1 lacked a care plan for apixaban use.
How serious are these violations?
Violation severity varies from minor documentation issues to serious safety concerns. Review the inspection report for specific deficiency codes and scope. All violations must be corrected within required timeframes and are subject to follow-up verification inspections.
What should families do?
Families should: (1) Ask facility administration about specific corrective actions taken, (2) Request to see the follow-up inspection report verifying corrections, (3) Check if this represents a pattern by reviewing prior inspection reports, (4) Compare this facility's ratings with other nursing homes in GLENDALE, CA, (5) Report any new concerns directly to state authorities.
Where can I see the full inspection report?
The complete inspection report is available on Medicare.gov's Care Compare website (www.medicare.gov/care-compare). You can also request a copy directly from GLENDALE HEALTHCARE CENTER or from the state Department of Health. The report includes specific deficiency codes, facility responses, and correction timelines. This facility's federal provider number is 555609.
Has this facility had violations before?
To check GLENDALE HEALTHCARE CENTER's history, visit Medicare.gov's Care Compare and review their inspection history, quality ratings, and staffing levels. Look for patterns of repeated violations, especially in critical areas like abuse prevention, medication management, infection control, and resident safety.